Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion (“RI”) Liquid Formulation in Japan

Go back to Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion (“RI”) Liquid Formulation in Japan
EAGLE PHARMACEUT (NASDAQ: EGRX) Delayed: 2.14 --0 (-0%)
Previous Close $2.14    52 Week High $102.48 
Open $2.14    52 Week Low $33.02 
Day High $2.14    P/E N/A 
Day Low $2.14    EPS $-1.02 
Volume 215